开发一个核心的结局设置营养护理的成年门诊病人,易怒肠综合征 (COS-RD-IBS研究)
Sandra Jent1, Joya Jelena Kristin Lüthi1, André Meichtry1
1Bern University of Applied Sciences, Department of Health Professions, Murtenstrasse 10, 3011 Bern, Switzerland.
Clinical nutrition ESPEN
|February 24, 2025
概括
一个核心结果集 (COS) 已开发,以标准化对刺激性肠综合征 (IBS) 营养护理的评估. 这套14项结果旨在提高对IBS患者的饮食干预措施评估的一致性.
科学领域:
- 胃肠病学和营养科学 胃肠病学和营养科学
- 临床研究方法论 临床研究方法论
背景情况:
- 刺激性肠综合征 (IBS) 是一种常见的肠-大脑轴障碍.
- 营养干预是IBS管理的关键,但结果评估缺乏标准化.
- 为了在IBS中一致评估营养护理,需要就核心结果集 (COS) 达成共识.
研究的目的:
- 为IBS或食物不耐受症的成年人提供饮食师提供的营养护理制定COS.
- 建立在IBS管理中的常规门诊实践的标准化结果.
主要方法:
- 从研究,COS,指导方针和患者的意见中编制了一个全面的结果列表.
- 进行了三轮的德尔菲过程,涉及192名参与者 (患者,营养学家,胃肠科医生,决策者).
- 结果根据重要性进行评分,并由不同的利益相关者小组排名.
主要成果:
- 在两轮德尔菲会议后,在14个结果上达成共识.
- 关键结果包括症状触发因素,饮食坚持,消化系统症状 (疼痛,胀气),便特征和生活质量 (身体,营养,社会功能).
- 授权自我照顾也被确定为一个关键的结果.
结论:
- 为IBS的营养护理建立了一个14个结果的COS.
- 这个COS提供了一个标准化的框架来评估饮食干预措施.
- 需要进一步的研究来完善COS,并确定用于常规实施的特定测量工具.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
295
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
295
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
108
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
108
Irritable Bowel Syndrome III: Medical and Nursing Management
139
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
139
Irritable Bowel Syndrome I: Introduction
219
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
219
Chronic Bowel Disorders: Introduction
378
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
378
Drugs for Treatment of Constipation-Predominant IBS
125
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
125


